Filter & search
Fund strategy:
Loading...
These were all team members
a9a5cc2c88
Menu
Menu
Our transatlantic team, comprising sector specialists with operating and financial backgrounds, leverages its deep industry knowledge to achieve outsized returns on companies that deliver better care at lower costs.
The Venture&Growth fund is managed by a dedicated investment team and is focused on:
- healthtech and therapeutics
- early revenue stage or clinical stage
- equity investments of up to €50 million per portfolio company
- Europe and North America
- significant minority ownership
See Venture&Growth Portfolio for an overview of the portfolio.